4.8 Article

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination

期刊

ELIFE
卷 10, 期 -, 页码 -

出版社

eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.62997

关键词

-

类别

资金

  1. Bill and Melinda Gates Foundation [OPP11188166, OPP1204268]
  2. Wellcome Trust [098051, 206194, 203141, 090770, 204911, 106698/B/14/Z]
  3. Medical Research Council [G0600718]
  4. Department for International Development, UK Government [201900, M006212]
  5. MRC [G0600718] Funding Source: UKRI
  6. Bill and Melinda Gates Foundation [OPP1204268] Funding Source: Bill and Melinda Gates Foundation
  7. Wellcome Trust [106698/B/14/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

GenRe-Mekong is a platform for genetic surveillance of malaria in the Greater Mekong Subregion, providing valuable insights and aiding decision-making for NMCPs. It offers detailed knowledge about drug resistance, facilitates data sharing, and enables cross-border resistance monitoring, benefiting the malaria community as a whole.
Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据